EGFR-IN-143

EGFR-IN-143 (Compound 5f) is a potent EGFR inhibitor exhibiting an IC50 of 0.15 μM. It demonstrates antitumor activity by inducing apoptosis and causing G2/M phase cell cycle arrest, making it a valuable tool for cancer research in both in vitro and in vivo experimental models.